eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
Original paper

Pruritus prevalence and characteristics in Care and Treatment Facility and Geriatric Outpatient Clinic patients: a cross-sectional study using a standardized pruritus questionnaires

Paula Mazan
1
,
Aleksandra Lesiak
1
,
Małgorzata Skibińska
2
,
Monika Rynkowska-Kidawa
3
,
Igor Bednarski
4
,
Dorota Sobolewska-Sztychny
1
,
Marcin Noweta
1
,
Joanna Narbutt
1

  1. Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, Poland
  2. Department of Dermatology, Paediatric Dermatology and Oncology, Biegański Memorial Provincial Specialist Hospital, Lodz, Poland
  3. Care and Treatment Facility, Jonscher Memorial City Medial Center, Lodz, Poland
  4. Department of Neurology and Stroke, Medical University of Lodz, Poland
Adv Dermatol Allergol
Online publish date: 2024/10/29
Article file
- Pruritus.pdf  [0.18 MB]
Get citation
 
 
1. Valdes-Rodriguez R, Mollanazar NK, González-Muro J, et al. Itch prevalence and characteristics in a Hispanic geriatric population: a comprehensive study using a standardized itch questionnaire. Acta Derm Venereol 2015; 95: 417-21.
2. Yalcin B, Tamer E, Gur Toy G, et al. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol 2006; 45: 672-6.
3. Gunalan P, Indradevi R, Oudeacoumar P, et al. Pattern of skin diseases in geriatric patients attending tertiary care centre. J Evol Med Dent Sci 2017; 6: 1566-70.
4. Long CC, Marks R. Stratum corneum changes in patients with senile pruritus. J Am Acad Dermatol 1992; 27: 560-4.
5. Berger TG, Steinhoff M. Pruritus in elderly patients – eruptions of senescence. Semin Cutan Med Surg 2011; 30: 113-7.
6. Berger TG, Shive M, Harper GM. Pruritus in the older patient: a clinical review. JAMA 2013; 310: 2443-50.
7. Steinhoff M, Schmelz M, Szabó IL, et al. Clinical presentation, management, and pathophysiology of neuropathic itch. Lancet Neurol 2018; 17: 709-20.
8. Canavero S, Bonicalzi V, Massa-Micon B. Central neurogenic pruritus: a literature review. Acta Neurol Belg 1997; 97: 244-7.
9. Candore G, Caruso C, Jirillo E, et al. Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Curr Pharm Des 2010; 16: 584-96.
10. Pawelec G, Larbi A, Derhovanessian E. Senescence of the human immune system. J Comp Pathol 2010; 142 (Suppl 1): S39-44.
11. Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int 2009; 22: 1041-50.
12. Candore G, Caruso C, Jirillo E, et al. Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Curr Pharm Des 2010; 16: 584-96.
13. Dalgard F, Dawn A, Yosipovich G. Are itch and chronic pain associated in adults? Results of a large population survey in Norway. Dermatology 2007; 214: 305-9.
14. Bożek A, Reich A. Validity assessment of the 10-Item Pruritus Severity Scale. Forum Dermatologicum 2018; 4: 91-5.
15. Reich A, Heisig M, Phan NQ, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012; 92: 497-501.
16. Serup J. EEMCO guidance for the assessment of dry skin (xerosis) and ichthyosis: clinical scoring systems. Skin Res Technol 1995; 1: 109-14.
17. Silverberg JI, Hinami K, Trick WE, et al. Itch in the general internal medicine setting: a cross-sectional study of prevalence and quality-of-life effects. Am J Clin Dermatol 2016; 17: 681-90.
18. Reszke R, Białynicki-Birula R, Lindner K, et al. Itch in elderly people: a cross-sectional study. Acta Derm Venereol 2019; 99: 1016-21.
19. Stefaniak AA, Krajewski PK, Bednarska-Chabowska D, et al. Itch in adult population with type 2 diabetes mellitus: clinical profile, pathogenesis and disease-related burden in a cross-sectional study. Biology (Basel) 2021; 10: 1332.
20. Yamaoka H, Sasaki H, Yamasaki H, et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care 2010; 33: 150-5.
21. White-Chu EF, Reddy M. Dry skin in the elderly: complexities of a common problem. Clin Dermatol 2011; 29: 37-42.
22. Yosipovitch G. Dry skin and impairment of barrier function associated with itch – new insights. Int J Cosmet Sci 2004; 26: 1-7.
23. Chung BY, Um JY, Kim, JC, et al. Pathophysiology and treatment of pruritus in elderly. Int J Mol Sci 2021; 22: 174.
24. Anees M, Butt G, Gull S, et al. Factors affecting dermatological manifestations in patients with end stage renal disease. J Coll Physicians Surg Pak 2018; 28: 98-102.
25. Dwiyana RF, Tsaqilah L, Sukesi L, et al. Characteristics of xerosis, pruritus, and pallor in stage 5 chronic kidney disease patients undergoing hemodialysis at Dr. Hasan Sadikin General Hospital, Bandung. Clin Cosmet Investig Dermatol 2023; 16: 2613-21.
26. von Stülpnagel CC, Augustin M, da Silva N, et al. Exploring the burden of xerosis cutis and the impact of dermatological skin care from patient’s perspective. J Dermatolog Treat 2022; 33: 2482-7.
27. Meijer JM, Diercks GFH, de Lang EWG, et al. Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid. JAMA Dermatol 2019; 155: 158-65.
28. Meijer JM, Lamberts A, Luijendijk HJ, et al. Prevalence of pemphigoid as a potentially unrecognized cause of pruritus in nursing home residents. JAMA Dermatol 2019; 155: 1423-4.
29. Lamberts A, Meijer JM, Pas HH, et al. Nonbullous pemphigoid: insights in clinical and diagnostic findings, treatment responses, and prognosis. J Am Acad Dermatol 2019; 81: 355-63.
30. Razykov I, Thombs BD, Hudson M, et al. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Rheum 2009; 61: 1765-70.
31. El-Baalbaki G, Razykov I, Hudson M, et al. The association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care Res (Hoboken) 2010; 62: 1489-95.
32. Frech TM, Baron M. Understanding itch in systemic sclerosis in order to improve patient quality of life. Clin Exp Rheumatol 2013; 31 (2 Suppl 76): 81-8.
33. Pereira MP, Ständer S. Therapy for pruritus in the elderly: a review of treatment developments. Expert Opin Pharmacother 2018; 19: 443-50.
34. Sneddon IB, Garretts M. The significance of low serum iron levels in the causation of itching. Proc 12th Int Congress Dermatol, Munich. 1967; 2: 1061-3.
35. Saini S, Jain AK, Agarwal S, et al. Iron deficiency and pruritus: a cross-sectional analysis to assess its association and relationship. Indian J Dermatol 2021; 66: 705.
36. Phan NQ, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2012; 92: 502-7.
37. Wang X, Lai Q, Zheng B, et al. Both prevalence and severity of pruritus are associated with age in Chinese patients with skin diseases. Clin Cosmet Investig Dermatol 2021; 14: 217-23.
38. Jang YH, Kim SM, Eun DH, et al. Validity and reliability of itch assessment scales for chronic pruritus in adults: a prospective multicenter study. J Am Acad Dermatol 2020; 82: 80-6.
39. Storck M, Sandmann S, Bruland P, et al. Pruritus intensity scales across Europe: a prospective validation study. J Eur Acad Dermatol Venereol 2021; 35: 1176-85.
40. Reich A, Ständer S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol 2009; 89: 236-44.
41. Gade A, Matin T, Rubenstein R. Xeroderma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.